Zealand Pharma A/S (ZLDPF)

PNK: ZLDPF · Real-Time Price · USD

75.15

4.82 (6.85%)

At close: May 02, 2025, 3:31 PM

Zealand Pharma A/S Income Statement

Financials in DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	62.69M	342.79M	103.99M	292.57M	353.31M	41.33M	37.98M	139.78M	234.78M
Cost of Revenue	7.87M	19.17M	30.71M	118.81M	90.56M	415K	180.24M	14.63M	31.46M
Gross Profit	54.82M	323.61M	73.28M	173.75M	262.75M	40.92M	-142.26M	125.15M	203.32M
Operating Income	-1.27B	-572.24M	-816.6M	-1.05B	-828.76M	-587.94M	652.39M	-246.38M	-115.65M
Interest Income	169.64M	45.32M	6.54M	44K	895K	5.41M	4.26M	2.05M	592K
Pretax Income	-1.08B	-708.87M	-972.04M	-1.03B	-839.65M	-576.68M	625.06M	-277.77M	-159.41M
Net Income	-1.08B	-703.74M	-965.61M	-1.02B	-846.73M	-571.54M	581.28M	-272.27M	-153.91M
Selling & General & Admin	229.2M	89.85M	306.54M	636.26M	488.03M	67.88M	78M	47.47M	52.5M
Research & Development	919.87M	684.9M	614.04M	588.45M	604.08M	561.42M	438.21M	324.67M	268.16M
Other Expenses	177.96M	121.1M	n/a	-759K	-602K	-444K	1.1B	n/a	777K
Operating Expenses	1.33B	895.85M	920.59M	1.22B	1.09B	628.86M	515.59M	371.53M	318.96M
Interest Expense	34.05M	24.89M	56.45M	4.09M	2.9M	3.21M	15.08M	18.91M	32.16M
Selling & Marketing Expenses	68.69M	16.05M	32.3M	375.27M	285.26M	n/a	n/a	n/a	n/a
Cost & Expenses	1.33B	915.03M	920.59M	1.34B	1.18B	629.27M	695.82M	386.16M	350.42M
Income Tax Expense	-4.62M	-5.13M	-6.43M	-8.79M	7.08M	-5.14M	43.77M	-5.5M	-5.5M
Shares Outstanding (Basic)	66.43M	56.59M	46.2M	42.87M	38.37M	33.8M	30.69M	27.85M	24.31M
Shares Outstanding (Diluted)	66.43M	56.59M	46.2M	42.87M	38.37M	33.8M	30.7M	27.85M	24.31M
EPS (Basic)	-16.24	-12.44	-20.9	-23.75	-22.07	-16.91	18.94	-9.77	-6.33
EPS (Diluted)	-16.24	-12.44	-20.9	-23.75	-22.07	-16.91	18.94	-9.77	-6.33
EBITDA	-1.02B	-657.95M	-665.26M	-711.85M	-627.94M	-562.64M	-442M	-246.28M	-118.27M
EBIT	-1.05B	-683.03M	-915.59M	-754.8M	-670.63M	-573.47M	640.13M	-261M	-130.64M
Depreciation & Amortization	25.85M	25.09M	30.71M	25.12M	42.69M	13.54M	4.51M	4.76M	5.41M